2019
DOI: 10.1002/fsn3.1029
|View full text |Cite
|
Sign up to set email alerts
|

Capability of polygonum cuspidatum extract in inhibiting AGEs and preventing diabetes

Abstract: Diabetes is a metabolic disorder disease associated with advanced glycation end products (AGEs) and protein glycation. The effect of polygonum cuspidatum extract (PE) on AGEs and Nε‐(Carboxymethyl)‐L‐lysine formation, protein glycation, and diabetes was investigated. Six primary phenolics in a range of 12.36 mg/g for ellagic acid to 0.01 mg/g for piceid were determined in PE. In an intermediate‐moisture‐foods model, inhibition rate of PE was as high as 54.2% for AGEs and 78.9% for CML under aw 0.75. The protei… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 53 publications
0
9
0
Order By: Relevance
“…Curcuma zedoaria (Zingiberaceae) is reported to inhibit the development of gastric carcinoma, breast cancer as well as liver cancer [11][12][13][14]. Polygonum cuspidatum is used for the therapy of multiple diseases including hypertension, diabetes, and atherosclerosis [15][16][17], and its extracts have been reported with anticancer effects in lung cancer, osteosarcoma, and breast cancer [18][19][20]. The extracts of Rhizoma Paridis is revealed to suppress the cancer development in non-small-cell lung carcinoma, colon cancer, and hepatocarcinoma [21][22][23].…”
Section: Introductionmentioning
confidence: 99%
“…Curcuma zedoaria (Zingiberaceae) is reported to inhibit the development of gastric carcinoma, breast cancer as well as liver cancer [11][12][13][14]. Polygonum cuspidatum is used for the therapy of multiple diseases including hypertension, diabetes, and atherosclerosis [15][16][17], and its extracts have been reported with anticancer effects in lung cancer, osteosarcoma, and breast cancer [18][19][20]. The extracts of Rhizoma Paridis is revealed to suppress the cancer development in non-small-cell lung carcinoma, colon cancer, and hepatocarcinoma [21][22][23].…”
Section: Introductionmentioning
confidence: 99%
“…Oral gavage PCE was performed in the treatment group at the level of 0.2 g/kg of body weight. Sheng found that PCE could reduce the blood sugar of diabetic rats and make lipid indexes such as LDL-C, HDL-C, and TG tend to be normal ( Sheng et al, 2019 ).…”
Section: Biological Activitiesmentioning
confidence: 99%
“…Previous studies conducted on R. japonica leaf extracts indicate an antiglycation potential of these plants [17]. Moreover, studies in diabetic rats have shown that R. japonica rhizome extract reduced streptozotocin-induced early podocyte damage in the kidneys, and its active ingredient, emodin, inhibited methylglyoxal-mediated protein glycation [18].…”
Section: Introductionmentioning
confidence: 96%